Everyone has their own investment criteria and timelines. Where I would disagree with you is that we are well past the proof of efficacy for Bisantrene - the more than 40 historical trials and not least the recent Phase 2 trial in Israel are more than enough proof Bisantrene works. Where we don’t have clinical proof is the FTO mechanism of action (Pillar 1), but there are some vey interesting results in the historical data that support this mechanism of action.
I would also like to add that none of the directors want to sell despite owning a boat load of shares.
but out price, page-57
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
0.000(0.00%) |
Mkt cap ! $247.1M | |||
| Open | High | Low | Value | Volume |
| $1.45 | $1.45 | $1.35 | $254.2K | 185.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 212 | $1.40 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 5981 | 3 |
View Market Depth
| Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |